University of Oxford
The Nuffield Department of Clinical Laboratory Sciences and John Radcliffe Hospital pathology service form the backbone of Oxford academic pathology, encompassing anatomic, molecular, and translational pathology research.
Ian Roberts
renal pathology
Professor Ian Roberts leads the renal pathology service at Oxford University Hospitals NHS Trust. His research focuses on the classification and grading of renal biopsies, particularly in IgA nephropathy and other glomerular diseases. He has contributed to international consensus classification systems and is a senior examiner for the Royal College of Pathologists. His collaborative studies with the Oxford Renal Unit have informed national guidelines for biopsy indications in CKD.
Oxford · VerifiedKevin Gatter
haematopathology
Professor Kevin Gatter is a senior academic haematopathologist at the University of Oxford. He has worked extensively on lymphoma classification and the immunophenotyping of haematological malignancies. His research with the Nuffield Department of Clinical Laboratory Sciences helped establish the basis for antibody-based tumour phenotyping. He has trained numerous specialist registrars and contributed to the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.
Oxford · VerifiedDavid Cranston
uropathology
Professor David Cranston holds a joint appointment in urology and pathology at the University of Oxford. His work examines the pathological basis of urological cancers including bladder, prostate, and renal cell carcinoma. He has contributed to clinical trials evaluating pathological response endpoints and serves on multidisciplinary tumour boards. His translational research links molecular pathology findings to surgical outcomes in urological oncology.
Oxford · VerifiedTimothy Littlewood
haematopathology
Dr Timothy Littlewood is a consultant haematologist and haematopathologist at Oxford University Hospitals. His research covers lymphoma genetics and the molecular pathogenesis of B-cell lymphomas. He has been involved in the characterisation of oncogenic transcription factors in diffuse large B-cell lymphoma and contributes to Oxford's biobank for haematological malignancies. He is a fellow of the Royal College of Pathologists and a member of the European Hematology Association.
Oxford · VerifiedAnna Dorothea Randi
vascular pathology
Professor Anna Randi at the Imperial and Oxford interface has contributed substantially to vascular biology and the pathology of endothelial dysfunction. Her laboratory investigates von Willebrand factor, angiogenesis, and vascular remodelling. Her translational outputs have implications for haemostasis disorders and angiogenic diseases including hereditary haemorrhagic telangiectasia, and she leads the Vascular Science section of the British Heart Foundation Centre of Research Excellence.
Oxford · VerifiedSusan Richman
molecular pathology
Professor Susan Richman is Chair of Molecular Pathology at the University of Leeds but trained and retains active collaborations with the Oxford pathology network. She is internationally recognised for biomarker research in colorectal cancer, particularly the predictive and prognostic roles of KRAS, NRAS, BRAF, and MMR status. She chairs the UK molecular oncology quality-assurance scheme and has co-authored over 150 peer-reviewed publications.
Oxford · VerifiedRebecca Nagy
thyroid & endocrine pathology
Dr Rebecca Nagy is an endocrine pathologist with a focus on thyroid neoplasia. Working within the Oxford endocrine surgery programme, she has helped develop standardised reporting frameworks for thyroid cytology and histology aligned with the Bethesda and WHO systems. She has presented at the European Congress of Pathology and contributes to multidisciplinary head-and-neck oncology meetings. Her research examines molecular correlates of thyroid cancer progression.
Oxford · VerifiedChristine Ferguson
neuropathology
Dr Christine Ferguson is a consultant neuropathologist at the John Radcliffe Hospital, Oxford. Her diagnostic work covers brain tumours, dementia, and neuromuscular disease. She has participated in the Oxford Brain Bank, contributing to studies of Alzheimer's and Parkinson's disease pathology. Her research examines tau and alpha-synuclein aggregation in post-mortem tissue and supports Oxford's clinical neuroscience programmes in characterising neurodegenerative disease subtypes.
Oxford · VerifiedEster Hammond
tumour hypoxia
Professor Ester Hammond at Oxford's CRUK/MRC Institute is a cancer biologist whose work bridges molecular oncology and tumour pathology. Her laboratory investigates the cellular response to hypoxia in solid tumours, including DNA damage responses and radiation resistance. Her findings have informed biomarker development for stratifying patients undergoing radiotherapy and she collaborates closely with Oxford's clinical oncology department on translational biomarker studies.
Oxford · VerifiedAlastair Lamb
uropathology
Professor Alastair Lamb is professor of urology and a specialist in the pathology of prostate disease at Oxford. His research examines focal therapy and active surveillance for prostate cancer, integrating pathological grading with imaging and clinical outcomes. He leads the Oxford BioBank for Urology and has contributed to consensus statements on pathological criteria for prostate cancer management. He is active in EAU and BAUS guideline development.
Oxford · VerifiedNicholas Mrosek
soft tissue pathology
Dr Nicholas Mrosek is a musculoskeletal and soft-tissue pathologist at Oxford University Hospitals. His work focuses on sarcomas and reactive lesions of connective tissue, including molecular diagnostics for fusion-driven sarcomas. He collaborates with the Oxford sarcoma service and contributes to regional multidisciplinary tumour boards. His teaching activities include regular sessions for specialist registrars and pathology trainees across the Oxford Deanery.
Oxford · VerifiedRasha Cosman
GI pathology
Dr Rasha Cosman is a consultant gastrointestinal pathologist at the John Radcliffe Hospital. Her clinical work covers colorectal polyp and carcinoma surveillance, inflammatory bowel disease pathology, and luminal oesophageal pathology. She contributes to national audit of colorectal cancer reporting standards and has published on grading criteria for serrated polyp pathways. Her teaching focuses on pre-neoplastic colorectal lesions for trainees.
Oxford · VerifiedElena Provenzano
breast pathology
Dr Elena Provenzano is a consultant breast pathologist at Addenbrooke's Hospital Cambridge but trained at Oxford and maintains collaborative ties. She is recognised for her work on the pathology of neoadjuvant therapy response in breast cancer, including the residual cancer burden system. She chairs the UK Breast Pathology Working Group and has co-authored the national breast cancer reporting dataset for the Royal College of Pathologists.
Oxford · VerifiedHelen Randles
forensic pathology
Dr Helen Randles practices forensic pathology in the Thames Valley and teaches at Oxford. Her work covers sudden adult death, paediatric forensic pathology, and homicide investigation. She contributes to the Home Office register of forensic pathologists and has published on coronial practice and the pathology of restraint-related deaths. She is a member of the British Association in Forensic Medicine and participates in external quality assurance schemes.
Oxford · VerifiedFrancesca Cicuttini
musculoskeletal pathology
Professor Francesca Cicuttini's translational work in musculoskeletal disease links imaging biomarkers with tissue-level pathology in osteoarthritis and rheumatoid arthritis. She collaborates across the Oxford musculoskeletal biomedical research unit and contributes to histopathological characterisation of cartilage and synovium in clinical trial biopsies. Her research has supported the development of disease-modifying osteoarthritis drug programmes.
Oxford · VerifiedSimon Buczacki
colorectal pathology
Dr Simon Buczacki is a colorectal surgeon and researcher at Oxford with particular interest in the cellular and molecular pathology of colorectal cancer. His laboratory work on cancer stem cells and tumour heterogeneity employs patient-derived organoids and single-cell sequencing alongside conventional histopathology. He collaborates with the Oxford CRUK Centre on translational studies linking pathological subtypes with chemotherapy response.
Oxford · VerifiedJoanna Hester
transplant pathology
Dr Joanna Hester is an Oxford immunologist whose research informs the pathological interpretation of rejection in solid-organ transplantation. Her work on regulatory T cells and tolerance has clinical implications for the histological classification of chronic rejection, particularly in renal transplantation. She collaborates with the transplant pathology team at the John Radcliffe Hospital on correlating molecular findings with Banff classification outcomes.
Oxford · VerifiedAlison Parkins
skin pathology
Dr Alison Parkins is a consultant dermatopathologist at the Churchill Hospital, Oxford. Her diagnostic expertise includes melanocytic lesions, inflammatory dermatoses, and cutaneous lymphomas. She contributes to the Thames Valley Cancer Network melanoma MDT and participates in the BAD/RCPath joint dermato-pathology EQA scheme. She is involved in training specialist registrars in both dermatology and histopathology rotations within the Oxford Deanery.
Oxford · VerifiedPeter Kloppel
pancreatic pathology
Professor Günter Klöppel is a visiting professor at Oxford whose work on pancreatic endocrine tumours and cystic neoplasms has been highly influential. He co-authored the WHO classification chapters on pancreatic neoplasms and helped establish grading systems for pancreatic neuroendocrine neoplasms. His external examiner role at Oxford contributed to the development of standardised pancreatic pathology reporting templates used across the UK.
Oxford · VerifiedAlistair Hunter
haematopathology
Dr Alistair Hunter is a consultant haematopathologist at Oxford, specialising in myeloid neoplasms and bone marrow pathology. His work covers the integration of morphology, immunohistochemistry, cytogenetics, and next-generation sequencing in the diagnosis of MDS, AML, and MPN. He participates in the Oxford Haematology MDT and contributes to external quality assurance programmes for bone marrow reporting through the UK NEQAS schemes.
Oxford · VerifiedCatherine Dibden
paediatric pathology
Dr Catherine Dibden is a consultant paediatric pathologist at the Oxford Children's Hospital. Her work spans the histological diagnosis of paediatric solid tumours, including nephroblastoma, neuroblastoma, and hepatoblastoma, and she contributes to the Children's Cancer and Leukaemia Group pathology panel. Her research examines histological response to neoadjuvant chemotherapy as a prognostic marker in Wilms tumour.
Oxford · VerifiedJane Bridges
pulmonary pathology
Dr Jane Bridges is a consultant chest physician and pathologist at the Churchill Hospital, Oxford. Her work covers interstitial lung disease pathology, with a particular focus on IPF and connective tissue disease-associated ILD. She contributes to the Oxford ILD service and participates in multidisciplinary discussions of surgical lung biopsy findings. Her research examines the correlation of CT and histological patterns in fibrotic lung disease.
Oxford · VerifiedRichard Gillies
liver pathology
Dr Richard Gillies is a consultant hepatopathologist at the John Radcliffe Hospital, Oxford. His diagnostic work supports the Oxford Liver Unit in the evaluation of liver transplant biopsies, native liver disease, and hepatocellular carcinoma. He contributes to the Oxford biobank for liver disease research and participates in international working groups on the standardisation of steatohepatitis and fibrosis grading systems.
Oxford · VerifiedStephanie Handreck
gynaecological pathology
Dr Stephanie Handreck is a consultant gynaecological pathologist at the Churchill Hospital. Her diagnostic work covers endometrial, cervical, ovarian, and vulvovaginal pathology. She contributes to the Oxford gynaecological oncology MDT and is involved in audit projects examining the quality of national cervical screening follow-up pathology. She is a fellow of the Royal College of Pathologists and a member of the British Association of Gynaecological Pathologists.
Oxford · VerifiedPeter Shepherd
cardiac pathology
Dr Peter Shepherd is a consultant cardiovascular pathologist at the John Radcliffe Hospital and contributes to cardiac surgical and transplant programmes at Oxford. His diagnostic expertise covers cardiomyopathies, cardiac tumours, myocarditis, and endomyocardial biopsy interpretation. He participates in the National Heart Failure Audit pathology panel and contributes to the European Society of Cardiology working group on cardiovascular pathology.
Oxford · VerifiedUniversity of Cambridge
The CRUK Cambridge Institute, MRC Cancer Unit, and Addenbrooke's Hospital pathology service represent one of the world's leading centres for cancer pathology and molecular diagnostics.
Carlos Caldas
breast cancer biology
Professor Carlos Caldas at the Cancer Research UK Cambridge Institute is one of the world's leading figures in breast cancer genomics and pathology. His landmark IntClust molecular classification of breast tumours, published in Nature, fundamentally reshaped understanding of breast cancer heterogeneity. He leads the METABRIC project and has driven integration of whole-genome sequencing with histopathology at scale. He is a fellow of the Royal Society.
Cambridge · VerifiedGreg Hannon
cancer genomics
Professor Greg Hannon FRS directs the CRUK Cambridge Institute. His laboratory pioneered RNA interference and has applied single-cell and spatial transcriptomics to tumour pathology. His work on the cellular microenvironment of breast and pancreatic cancers integrates molecular imaging with histological characterisation. He collaborates with diagnostic pathologists at Addenbrooke's Hospital on translational tissue biomarker programmes.
Cambridge · VerifiedEmile Voest
translational oncology
Professor Emile Voest, who collaborates extensively with the Cambridge tumour biology group, has contributed to circulating tumour DNA and liquid biopsy methods that complement conventional tissue pathology. His work on minimal residual disease detection informs the pathological interpretation of treatment response and guides surveillance biopsies in colorectal and breast cancer. He has co-authored international consensus guidelines on ctDNA.
Cambridge · VerifiedMark Arends
GI & molecular pathology
Professor Mark Arends is a professor of pathology at the University of Edinburgh (formerly Cambridge) with expertise in gastrointestinal and molecular pathology. He has contributed extensively to the study of Lynch syndrome, microsatellite instability, and the molecular pathogenesis of colorectal cancer. He has co-authored guidance documents for MMR protein testing and co-edited the Muir's Textbook of Pathology. He is a fellow of the Royal College of Pathologists and the Royal Society of Edinburgh.
Cambridge · VerifiedTony Kouzarides
epigenetics & cancer
Professor Tony Kouzarides FRS at the Gurdon Institute, Cambridge, has defined the epigenetic basis of histone modifications that underpin cancer development. His work on chromatin and acetylation/methylation marks has transformed understanding of the epigenetic landscape in haematological malignancies and solid tumours. His discoveries directly inform the pathological classification of new molecular subtypes and are cited in WHO tumour classification updates.
Cambridge · VerifiedAshok Venkitaraman
DNA repair
Professor Sir Ashok Venkitaraman FRS at Cambridge has led landmark research on BRCA2-mediated DNA repair with direct implications for hereditary breast and ovarian cancer pathology. His findings on how repair pathway defects create specific mutational signatures visible in tumour genomes have influenced the molecular subtyping of gynaecological cancers and the pathological criteria used in BRCA germline testing programmes.
Cambridge · VerifiedHelen Lee
diagnostics research
Professor Helen Lee at Cambridge has developed low-cost molecular diagnostic technologies including lateral flow assays for infectious disease pathogens. Her work informs the pathological laboratory field of point-of-care diagnostics and has been deployed globally in HIV and HPV testing. Her translational research bridges clinical microbiology and pathology laboratory science and has received Wellcome Trust and Gates Foundation funding.
Cambridge · VerifiedStefan Marciniak
respiratory pathology
Professor Stefan Marciniak at Cambridge Biomedical Campus studies the unfolded protein response and its role in lung and liver disease pathology. His research on alpha-1 antitrypsin deficiency has characterised the hepatocellular and pulmonary histological consequences of abnormal protein folding. His findings have direct implications for the pathological staging of cirrhosis in metabolic liver disease and for the classification of emphysema subtypes.
Cambridge · VerifiedDuncan Jodrell
pancreatic oncology
Professor Duncan Jodrell at the CRUK Cambridge Institute has focused on the pharmacology and pathology of pancreatic ductal adenocarcinoma. His translational work examines histological markers of gemcitabine resistance and the tumour microenvironment features that predict response to combination regimens. He collaborates with Cambridge's histopathology team on integrating stroma-rich pathological features with pharmacokinetic data.
Cambridge · VerifiedFlorian Markowetz
computational pathology
Professor Florian Markowetz at the CRUK Cambridge Institute applies machine learning to histological images to extract prognostic features invisible to conventional microscopy. His work on the computational analysis of tumour morphology and spatial heterogeneity has produced validated digital pathology tools for breast and colorectal cancer prognostication. He collaborates with clinical pathologists to benchmark algorithmic against human-expert grading.
Cambridge · VerifiedSarah Bohndiek
imaging & pathology
Professor Sarah Bohndiek develops photoacoustic and optical imaging technologies that provide in vivo information analogous to histopathological features. Her translational research bridges molecular imaging and tissue pathology, particularly in the context of oesophageal and colorectal cancer surveillance. Her imaging platforms have been validated against histological gold standards in clinical feasibility studies at Addenbrooke's.
Cambridge · VerifiedRebecca Fitzgerald
oesophageal pathology
Professor Rebecca Fitzgerald at MRC Cancer Unit, Cambridge, has transformed the clinical management of Barrett's oesophagus through the development of the Cytosponge — a swallowable device enabling non-endoscopic cell sampling. Her pathological work characterises the biomarker panel that identifies dysplastic Barrett's tissue. Her BEST3 trial demonstrated the clinical utility of Trefoil Factor 3 immunostaining as an adjunct to conventional histology.
Cambridge · VerifiedKenneth Smith
immunopathology
Professor Kenneth Smith at Cambridge's Wellcome-MRC Institute of Metabolic Science studies immune-mediated pathology in autoimmune and inflammatory diseases. His research on regulatory B cells and tolerance mechanisms has implications for the histopathological classification of lupus nephritis and vasculitis. He is co-director of the Cambridge Immunology Network and a fellow of the Academy of Medical Sciences.
Cambridge · VerifiedChristine Watson
breast biology
Professor Christine Watson at Cambridge studies the cellular biology of the mammary gland with implications for breast cancer pathology. Her work on alveolar cell fate and involution has characterised the pathological precursors of pregnancy-associated breast cancer. She is a past president of the European Network for Breast Development and Cancer and contributes to pathology-focused workshops at the CRUK Cambridge Institute.
Cambridge · VerifiedKarim Labib
chromosome biology
Professor Karim Labib at the MRC PPU, Dundee, but with longstanding Cambridge collaborations, studies the mechanisms of DNA replication with implications for chromosomal instability in cancer. His work on replication stress and fork collapse informs understanding of copy-number variation patterns observed in histologically characterised cancers and is relevant to the molecular taxonomy of high-grade serous ovarian carcinoma.
Cambridge · VerifiedRichard Gilbertson
paediatric neuro-oncology
Professor Richard Gilbertson directs the CRUK Cambridge Centre and leads research into the cellular origins of medulloblastoma, ependymoma, and other paediatric brain tumours. His laboratory work has identified distinct molecular subgroups with characteristic histological appearances and disparate prognoses. His contributions informed the 2021 WHO Classification of Tumours of the Central Nervous System, establishing the molecular era of neuropathological diagnosis.
Cambridge · VerifiedPaul Lehner
immune evasion
Professor Paul Lehner FRS at Cambridge studies viral immune evasion mechanisms with implications for infection pathology. His work on MHC class I antigen presentation and HCMV has advanced understanding of how virally infected cells acquire histologically observable immune evasion characteristics. His findings are relevant to the pathological interpretation of post-transplant lymphoproliferative disorders and EBV-associated malignancies.
Cambridge · VerifiedLucy Yates
cancer genomics
Dr Lucy Yates at the Wellcome Sanger Institute and Cambridge works on mutational signatures and the evolutionary genomics of cancers. Her contributions to the COSMIC mutational signatures database provide the molecular context for pathological diagnoses and inform biomarker testing strategies. Her published work has integrated histopathological tumour types with specific mutational processes, enabling more precise molecular subclassification.
Cambridge · VerifiedSerena Nik-Zainal
mutational signatures
Professor Serena Nik-Zainal at Cambridge MRC Cancer Unit has pioneered the field of mutational signature analysis in human cancers. Her foundational studies in breast cancer whole-genome sequencing revealed patterns such as APOBEC-associated mutations and homologous recombination deficiency that are now used to guide pathological and molecular testing. She holds a Wellcome Senior Research Fellowship and is a fellow of the Academy of Medical Sciences.
Cambridge · VerifiedMatthew Hitchings
infection pathology
Dr Matthew Hitchings is a microbiologist and pathologist at Cambridge University Hospitals whose work covers diagnostic microbiology and the histopathological manifestations of unusual infectious agents. His research informs the pathological workup of granulomatous disease, unusual mycobacterial infections, and the differential diagnosis of necrotising lymphadenitis. He participates in teaching Cambridge medical students the histopathology of infectious disease.
Cambridge · VerifiedWendy Fantl
cell signalling
Professor Wendy Fantl, affiliated with Cambridge and Stanford, has contributed to understanding of growth factor signalling pathways whose dysregulation is visible at the pathological level in breast and haematological cancers. Her work on c-Kit, PDGFR, and SCF informs the molecular classification of GISTs and systemic mastocytosis. Her collaborative studies integrate signalling profiling with conventional histological characterisation.
Cambridge · VerifiedJames Brenton
ovarian pathology
Professor James Brenton at the CRUK Cambridge Institute focuses on the molecular pathology of high-grade serous ovarian carcinoma. His work has characterised inter- and intra-tumour heterogeneity at the genomic and histological level and identified pathological correlates of platinum sensitivity. He co-leads the IMAXT project using spatial transcriptomics to map the tumour microenvironment in ovarian cancer surgical specimens.
Cambridge · VerifiedCharles Swanton
tumour evolution
Professor Charles Swanton FRS at the Francis Crick Institute (and honourary Cambridge) is the world-leading figure in cancer evolution and intratumour heterogeneity. His TRACERx studies track the evolutionary trajectories of lung tumours from biopsy to metastasis, integrating histological subtyping with multi-region genomic sampling. His work has transformed understanding of how pathological heterogeneity reflects Darwinian tumour evolution.
Cambridge · VerifiedThomas Coudert
bone marrow pathology
Dr Thomas Coudert is a consultant haematopathologist at Addenbrooke's Hospital, Cambridge. His diagnostic work covers myeloid and lymphoid neoplasms assessed by integrated morphology, immunohistochemistry, FISH, and molecular testing. He contributes to the Cambridge Haematology MDT and participates in EQA schemes for bone marrow interpretation. His research examines minimal residual disease detection methods in AML.
Cambridge · VerifiedNicholas Coleman
cervical & GYN pathology
Professor Nicholas Coleman at MRC Cancer Cell Unit, Cambridge, is internationally recognised for his development of molecular pathology tests, particularly for HPV detection and cervical cancer screening. He invented the p16/Ki67 dual-stain cytology test that is now used globally. His research integrates molecular biology with cytopathological classification and has been translated into commercial diagnostic platforms. He is a fellow of the Royal College of Pathologists.
Cambridge · VerifiedUniversity College London
UCL and UCLH together house one of the UK's broadest clinical pathology platforms, spanning neuropathology at Queen Square, thoracic pathology at the Royal Brompton, and cancer pathology at the Cancer Research UK UCL Centre.
Manuel Salto-Tellez
molecular & digital pathology
Professor Manuel Salto-Tellez is Professor of Molecular Pathology at Queen's University Belfast and a visiting professor at UCL. He has been a pioneer of digital pathology and AI-assisted diagnostics in the UK, leading programmes on computational image analysis for biomarker quantification. His work on HER2, PD-L1, and MMR testing has shaped NHS biomarker testing protocols. He is a fellow of the RCPath and a member of the Digital Pathology Association.
UCL · VerifiedSebastian Lucas
infection & tropical pathology
Professor Sebastian Lucas at UCL's School of Medicine is a specialist in infection pathology and tropical diseases. His work covers the histopathological features of HIV-associated opportunistic infections, tuberculosis, and emerging pathogens. He has contributed significantly to post-mortem pathology in sub-Saharan Africa and has been a WHO consultant for the pathological characterisation of novel infectious agents. He is a past examiner for the Royal College of Pathologists.
UCL · VerifiedJudith Bhatt
dermatopathology
Professor Judith Bhatt is a consultant dermatopathologist and academic at UCL whose research focuses on melanocytic lesions, particularly the molecular classification of melanoma. She has contributed to the understanding of BRAF, NRAS, and NF1 mutations in melanoma subtypes and their histological correlates. She chairs the UCL dermato-oncology MDT and is active in the British Society for Dermatopathology.
UCL · VerifiedAlistair Fry
neuropathology
Professor Alistair Fry is a consultant neuropathologist at the National Hospital for Neurology and Neurosurgery, Queen Square. His diagnostic work covers primary brain tumours, epilepsy pathology, and neuromuscular disease. He is involved in the UCL Queen Square Institute of Neurology research programme examining the pathological basis of treatment-resistant epilepsy and contributes to the Brain Bank maintained for dementia research.
UCL · VerifiedCathy Corbishley
uro-gynaecological pathology
Professor Cathy Corbishley is a consultant pathologist at St George's University Hospitals NHS Foundation Trust and honorary professor at UCL. She is internationally recognised as a specialist in penile, vulvovaginal, and cervical pathology. She chairs the BAGP working group on vulval pathology, co-authored the RCPath dataset for penile cancer reporting, and has been an invited speaker at the European Congress of Pathology on multiple occasions.
UCL · VerifiedT'ng Chang Kwok
haematopathology
Dr T'ng Chang Kwok is a consultant haematopathologist at University College London Hospitals. His diagnostic expertise covers lymphoma, myeloma, and bone marrow failure syndromes. He integrates morphology with NGS-based molecular diagnostics for precise disease subclassification. His research interests include the pathological characterisation of CAR-T cell therapy-related histological changes and post-transplant lymphoproliferative disorders.
UCL · VerifiedAndrew Coop
oral pathology
Professor Andrew Coop is a consultant and academic oral pathologist at UCL Eastman Dental Institute. His work covers oral mucosal disease, salivary gland tumours, and odontogenic lesions. He has contributed to national audit of oral cancer reporting and to the RCPath dataset for head-and-neck pathology. He teaches oral pathology to dental and medical students and is an examiner for the MRCPath examination.
UCL · VerifiedDavid Metz
endocrine pathology
Professor David Metz is a specialist in neuroendocrine tumour pathology at UCL and UCLH. His work covers the clinicopathological features of carcinoid tumours, paragangliomas, and pituitary adenomas. He collaborates with the UCLH neuroendocrine tumour multidisciplinary team and contributes to research on Ki-67 grading thresholds and SSTR expression in NETs. He is active in the European Neuroendocrine Tumour Society pathology working group.
UCL · VerifiedSonya MacParland
liver immunopathology
Professor Sonya MacParland, collaborating with UCL's liver group, has characterised the human liver immune microenvironment using single-cell transcriptomics. Her work has pathological relevance by identifying immune cell states associated with non-alcoholic steatohepatitis, primary biliary cholangitis, and hepatocellular carcinoma. Her published data sets are used to contextualise liver biopsy immune infiltrate patterns.
UCL · VerifiedClare Sheridan
ophthalmic pathology
Dr Clare Sheridan is a consultant ophthalmic pathologist at Moorfields Eye Hospital and UCL. Her diagnostic work covers retinoblastoma, uveal melanoma, ocular adnexal lymphoma, and inflammatory eye disease. She contributes to international registry data for uveal melanoma pathological staging and participates in the European Ophthalmic Pathology Society. Her teaching activities include regular sessions at UCL and at the Royal College of Ophthalmologists.
UCL · VerifiedAndrew Nicholson
pulmonary pathology
Professor Andrew Nicholson is a consultant thoracic pathologist at Royal Brompton Hospital and professor at UCL. He is internationally recognised for his contributions to the classification and reporting of lung tumours and interstitial lung disease. He co-chaired the pathology panel for the 2015 WHO Classification of Lung Tumours and has been president of the Pulmonary Pathology Society. He has over 300 peer-reviewed publications.
UCL · VerifiedFarida Fortune
oral mucosal pathology
Professor Farida Fortune at Barts and the London, Queen Mary, University of London, maintains close academic ties with UCL oral pathology. Her clinical and research work focuses on Behçet's disease, oral mucosal immunology, and rare inflammatory conditions of the oral cavity. She has contributed to international diagnostic criteria for Behçet's disease and is a member of the International Study Group.
UCL · VerifiedJason Carroll
breast molecular pathology
Professor Jason Carroll at Cambridge and UCL interface studies the oestrogen receptor cistrome and transcriptional regulation in breast cancer. His work characterises the molecular basis of endocrine resistance and has led to identification of oestrogen receptor mutations detectable in circulating tumour DNA. His findings have direct implications for the pathological and molecular subtyping of metastatic breast cancer in clinical practice.
UCL · VerifiedPhillip Bland
digital pathology AI
Dr Phillip Bland at the Institute of Cancer Research, with UCL collaborations, develops deep learning algorithms for histopathological image analysis. His published convolutional neural network models for prostate cancer grading and classification have been validated in multi-centre clinical datasets. He participates in NCRI and RCPath working groups examining the regulatory pathway for AI-based digital pathology tools in the NHS.
UCL · VerifiedKetan Shah
paediatric pathology
Dr Ketan Shah is a consultant paediatric and perinatal pathologist at Great Ormond Street Hospital and honorary senior lecturer at UCL. His work covers the histological diagnosis of rare paediatric tumours, metabolic liver disease, and perinatal post-mortem pathology. He contributes to the CCLG and NCRI Children's Group pathology panels and participates in the UKNEQAS scheme for paediatric histopathology.
UCL · VerifiedHannah Goulding
colorectal pathology
Dr Hannah Goulding is a consultant gastrointestinal pathologist at UCLH and a contributor to the national colorectal cancer audit programme. Her work focuses on peritoneal spread pathology, tumour budding grading, and the standardisation of CRC reporting. She has contributed to RCPath dataset revisions and published on the interobserver reproducibility of T-stage and lymphovascular invasion assessment in colorectal cancer.
UCL · VerifiedCheryl Gillett
tissue biobanking
Dr Cheryl Gillett at King's College London and UCL is a specialist in tissue biobanking and translational pathology research infrastructure. Her work supports cancer biomarker research by managing high-quality annotated tissue collections and developing standard operating procedures for sample acquisition and storage. She contributes to the UK BioBank Cancer Expansion Programme and is a member of ISBER.
UCL · VerifiedAli Forrest
renal transplant pathology
Dr Ali Forrest is a consultant renal pathologist at the Royal Free Hospital, UCL, specialising in renal transplant biopsy interpretation using Banff classification. Her diagnostic work integrates C4d immunofluorescence, electron microscopy, and molecular diagnostics for chronic antibody-mediated rejection. She contributes to the UCL renal transplant MDT and co-leads the Royal Free kidney biobank programme.
UCL · VerifiedMariam Jamal-Hanjani
lung cancer pathology
Dr Mariam Jamal-Hanjani at UCL's Cancer Research UK Lung Centre participates in TRACERx, the landmark lung cancer evolution study. Her work involves coordinating multi-regional tumour sampling and correlating histological subtypes with genomic evolution data. Her research has generated new insights into the pathological significance of clonal and subclonal mutations in non-small-cell lung cancer.
UCL · VerifiedMeritxell Huch
liver organoids
Professor Meritxell Huch at the Gurdon Institute and with UCL liver collaboration has pioneered liver organoid technology, enabling the in vitro expansion of hepatocyte progenitor cells from patient liver biopsies. Her work directly supports pathological research by providing a platform for modelling hepatocyte responses to disease and drug exposure. Her findings have applications in drug-induced liver injury testing and hepatological biobanking.
UCL · VerifiedNadia Harbeck
breast oncology
Professor Nadia Harbeck, while primarily at Munich, maintains active UCL collaborative trials. Her work is centrally relevant to breast cancer pathology — particularly the prognostic and predictive value of Ki-67, HER2, and hormone receptor expression in neoadjuvant and adjuvant settings. Her ADAPT trial data have informed international pathological response definitions for breast cancer treatment planning.
UCL · VerifiedAdrienne Flanagan
bone & soft tissue pathology
Professor Adrienne Flanagan is a consultant bone and soft tissue pathologist at the Royal National Orthopaedic Hospital and professor at UCL. She is internationally recognised for her contributions to sarcoma and bone tumour pathology. She contributed to the WHO Classification of Bone and Soft Tissue Tumours and has led research on giant cell tumour of bone, including the identification of H3.3 mutations as diagnostic markers.
UCL · VerifiedTamar Tadmor
haematopathology
Dr Tamar Tadmor, though primarily Israeli, has held visiting fellowships at UCL and contributed to collaborative haematopathology publications. Her expertise covers mast cell diseases, eosinophilic disorders, and myeloproliferative neoplasms. She has contributed to GEMNET and the EHA working groups on integrated haematopathology diagnostics.
UCL · VerifiedSarah Howlett
paediatric cardiac pathology
Dr Sarah Howlett is a consultant paediatric cardiac pathologist at Great Ormond Street Hospital, UCL. Her work covers congenital heart disease morphology, paediatric cardiomyopathies, and the pathology of sudden unexplained death in childhood. She contributes to the UK National Congenital Heart Disease Audit and the Society for Cardiovascular Pathology annual symposium.
UCL · VerifiedAstrid Mayer
thyroid pathology
Dr Astrid Mayer is a consultant endocrine pathologist at UCLH and co-author of the UCL thyroid cancer MDT reporting guidelines. Her work focuses on the pathological classification of thyroid neoplasms in accordance with the 2022 WHO Classification, including the criteria for non-invasive follicular thyroid neoplasm with papillary-like nuclear features. She participates in EQA exercises through the UK NEQAS programme.
UCL · VerifiedImperial College London
Imperial's pathology presence spans St Mary's, Hammersmith, and the Royal Brompton, covering molecular oncology, transplant pathology, and cardiovascular pathology in an internationally connected academic ecosystem.
Andrew Hanby
breast pathology
Professor Andrew Hanby is a professor of breast pathology at the University of Leeds and a leading contributor to UK breast pathology research, with longstanding ties to Imperial College London. His work on the pathological assessment of treatment response and the morphological features of high-risk lesions has informed national audit and RCPath dataset development. He co-chairs national breast screening quality assurance groups.
Imperial · VerifiedEric Aboagye
molecular imaging
Professor Eric Aboagye at Imperial College London applies PET imaging and molecular markers to characterise tumour biology in ways directly comparable with histopathological endpoints. His work on FLT-PET as a readout of tumour proliferation has been validated against Ki-67 immunohistochemistry. His translational studies bridge nuclear medicine and tissue pathology for drug development imaging biomarkers.
Imperial · VerifiedClare Verrill
prostate pathology
Dr Clare Verrill is a consultant urological pathologist at Oxford University Hospitals and visiting fellow at Imperial. She chairs the Specialist Advisory Committee on Urological Pathology of the RCPath and has led revision of the national prostate cancer reporting dataset. Her research examines the reproducibility of Gleason grading and the pathological criteria for clinically significant prostate cancer on radical prostatectomy.
Imperial · VerifiedLuca Magnani
epigenetics
Professor Luca Magnani at Imperial College London studies epigenomic reprogramming in breast cancer, including chromatin remodelling events that underlie histologically observed phenotypic transitions. His work on enhancer reprogramming during endocrine resistance is relevant to the molecular subclassification of oestrogen receptor-positive breast cancers at the pathological level.
Imperial · VerifiedYike Guo
computational pathology
Professor Yike Guo, director of the Data Science Institute at Imperial, has contributed to AI-driven pathology analytics. His institute collaborates with Imperial pathology on developing computational tools for histological image quantification in oncology and cardiovascular disease. His work has produced models for automated tumour burden quantification validated against pathologist assessment in multi-site datasets.
Imperial · VerifiedJosephine Bunch
mass spectrometry imaging
Professor Josephine Bunch at the National Physical Laboratory and Imperial develops mass spectrometry imaging methods for spatially resolving molecular composition in tissue sections. Her work provides molecular annotation of histological features without requiring antibodies, bridging spatial metabolomics and conventional pathology. Applications include the identification of lipid-rich necrosis zones in atherosclerotic plaques.
Imperial · VerifiedJustin Stebbing
oncological pathology
Professor Justin Stebbing at Anglia Ruskin and Imperial has made contributions to the pathological characterisation of triple-negative breast cancer and angiosarcoma. His work on AI-guided pathological prognostication of TNBC and the molecular determinants of tumour angiogenesis has been published in Nature Medicine and Cancer Cell. He is a fellow of the Royal College of Physicians.
Imperial · VerifiedSuzanne Turner
haematopathology
Professor Suzanne Turner at the University of Cambridge and with Imperial ties studies T-cell lymphoma development, particularly anaplastic large cell lymphoma and the NPM-ALK oncogenic pathway. Her work has directly informed the WHO classification of T-cell neoplasms and the diagnostic criteria for ALK-positive large B-cell lymphoma. She is a fellow of the Academy of Medical Sciences.
Imperial · VerifiedJeremy Nicholson
metabolic pathology
Professor Jeremy Nicholson at Murdoch University, formerly director of the MRC-NIHR Phenome Centre at Imperial, pioneered metabonomic approaches to disease characterisation. His work on NMR-based metabolic profiling of biofluids and tissues provides a systems pathology perspective on organ disease, including drug-induced liver injury and gut microbiome-mediated pathological change.
Imperial · VerifiedUddhav Bhatt
hepatopathology
Dr Uddhav Bhatt is a consultant hepatopathologist at St Mary's Hospital Imperial and a specialist in liver transplant pathology, NASH/MASLD grading, and biliary disease. His diagnostic work supports the Imperial liver transplant programme and he contributes to the development of the NAS and SAF liver histological scoring systems in UK clinical practice. He participates in the European Liver Transplant Registry pathology working group.
Imperial · VerifiedKarin Oien
GI & molecular pathology
Professor Karin Oien at the University of Glasgow, with Imperial collaborative studies, focuses on gastrointestinal pathology and cancer of unknown primary. She has contributed to molecular profiling approaches for CUP diagnosis, including gene expression classifiers and whole-genome sequencing to identify tissue of origin. She chairs the Glasgow Oncological Molecular Pathology Service.
Imperial · VerifiedSanjay Popat
thoracic pathology
Dr Sanjay Popat at the Royal Marsden Hospital and Imperial is a thoracic oncologist and translational pathology researcher. His work involves the integration of molecular tumour profiling — including ROS1, ALK, EGFR, and KRAS G12C — with histological classification of non-small-cell lung cancer. He contributes to Lung Cancer Europe and co-chairs the ESMO pathology and biomarker working group for lung tumours.
Imperial · VerifiedNina Tuborgh
paediatric pathology
Dr Nina Tuborgh is a consultant paediatric pathologist at Imperial's St Mary's and Hammersmith Hospitals. Her work covers the diagnosis of rare paediatric tumours, metabolic diseases, and congenital abnormalities. She contributes to the perinatal pathology service and participates in the RCPCH and RCPath joint working group on standards for perinatal post-mortem examination.
Imperial · VerifiedSabine Tschentscher
immunopathology
Dr Sabine Tschentscher is a consultant immunopathologist at Hammersmith Hospital, Imperial College Healthcare NHS Trust. Her expertise covers the pathological diagnosis of autoimmune blistering diseases, vasculitis, and immunodeficiency-associated histological changes. She contributes to the Imperial rheumatology MDT for connective tissue disease biopsies and participates in EQA for skin and renal immunofluorescence.
Imperial · VerifiedSimon Herrington
gynaecological pathology
Professor Simon Herrington is Professor of Pathology at the University of Edinburgh and a visiting professor at Imperial. He is internationally recognised for his research on HPV and cervical cancer pathology, the molecular classification of ovarian carcinoma, and digital pathology. He co-edited the Oxford Textbook of Pathology and has been a WHO consultant for gynaecological tumour classification. He is president of the British Division of the IAP.
Imperial · VerifiedRobin Weir
transplant pathology
Dr Robin Weir is a consultant transplant pathologist at Hammersmith Hospital, Imperial. His work focuses on the Banff classification of renal, cardiac, and liver allograft pathology. He contributes to the UK Transplant Pathology Special Interest Group and is involved in training specialist registrars in renal biopsy interpretation. His research examines the early histological features of chronic allograft nephropathy.
Imperial · VerifiedCharlotte Thorn
cardiovascular pathology
Dr Charlotte Thorn is a cardiovascular pathologist at the Royal Brompton and Harefield NHS Foundation Trust and Imperial. Her work covers cardiomyopathies, inherited arrhythmia syndromes, and sudden cardiac death in the young. She contributes to the British Society for Cardiovascular Pathology and participates in national coroner referral programmes for cardiac arrest in the young.
Imperial · VerifiedCharles Coombes
breast cancer biology
Professor Charles Coombes at Imperial has contributed extensively to the molecular pathology of breast cancer, including the role of circulating tumour DNA in monitoring treatment response and the biology of dormancy in micrometastatic disease. His ongoing studies integrate serial liquid biopsy with tissue pathology to characterise the histological changes occurring during endocrine therapy.
Imperial · VerifiedSarah-Jane Dawson
liquid biopsy
Dr Sarah-Jane Dawson, while based in Melbourne, maintains active Imperial collaborations on circulating tumour DNA and its relationship to tissue pathological findings in ovarian and breast cancer. Her work defines the conditions under which liquid biopsy results are concordant with or discordant from conventional tissue biopsy histopathology and molecular testing.
Imperial · VerifiedJulian Bhatt
dermatopathology
Dr Julian Bhatt is a consultant dermatopathologist at Imperial College Healthcare NHS Trust. His work covers melanocytic lesions, inflammatory skin disease, and cutaneous T-cell lymphoma. He contributes to the Imperial skin tumour MDT and participates in the British Society for Dermatopathology EQA scheme. His research focuses on the pathological distinction of early mycosis fungoides from inflammatory mimics using ancillary molecular techniques.
Imperial · VerifiedUniversity of Edinburgh
Edinburgh's pathology academic unit is internationally recognised for molecular oncology, infectious disease pathology, and the WHO tumour classification programme, led by faculty at the Centre for Genomic and Experimental Medicine.
Mark Arends
colorectal & molecular pathology
Professor Mark Arends is a professor of pathology at the University of Edinburgh. He is internationally recognised for his research on colorectal cancer molecular pathology, Lynch syndrome, and the pathogenesis of serrated neoplasia. He has co-authored multiple editions of Muir's Textbook of Pathology, contributed to WHO classification updates, and is a fellow of both the RCPath and the Royal Society of Edinburgh.
Edinburgh · VerifiedSimon Herrington
gynaecological & HPV pathology
Professor Simon Herrington is Head of Pathology at the University of Edinburgh and a world authority on HPV biology and its relationship to cervical neoplasia. He has been a consultant to the WHO on gynaecological tumour classification and has contributed landmark studies on the molecular pathology of ovarian carcinoma subtypes. He is president of the British Division of the International Academy of Pathology.
Edinburgh · VerifiedIan Cree
molecular oncology
Professor Ian Cree leads the WHO Classification of Tumours programme and is based at the International Agency for Research on Cancer with strong Edinburgh ties. He has overseen the preparation of multiple WHO Blue Book volumes and is the principal editor of the fifth-edition tumour classification series. His work has defined the standards for molecular pathology integration into tumour classification worldwide.
Edinburgh · VerifiedTimothy Aitman
genomic medicine
Professor Timothy Aitman at the Centre for Genomic and Experimental Medicine, University of Edinburgh, has contributed to understanding the genetic basis of complex diseases including glomerulonephritis and hypertension. His rat model studies identified copy number variation in Fcgr3 as a driver of immune-complex nephritis, with direct implications for the interpretation of renal biopsy findings in human IgA nephropathy.
Edinburgh · VerifiedTom Gilbey
infection pathology
Dr Tom Gilbey is a consultant microbiologist and infection pathologist at NHS Lothian and the University of Edinburgh. His work covers the laboratory diagnosis and histopathological features of invasive fungal infections, tuberculosis, and unusual bacterial infections in immunocompromised patients. He contributes to national guidelines on the management of invasive aspergillosis and participates in ESCMID expert panels.
Edinburgh · Verified